A key element of the AusBiotech 2018 conference is a one-day Early Stage Investment Forum featuring approximately 20 presentations from local research institutes, universities, hospitals and pre-series A companies in the area of human therapeutics and enabling technologies. The pitches will be made to an
expert investor panel that will include international big pharma representatives as well as corporate VCs
and early stage investors.
The forum will be open to AusBiotech attendees and will take place on Thursday 1 November at the AusBiotech 2018 national conference in Brisbane between 11.00am – 5.00pm.
Applicants are invited to submit their interest to be considered for a presentation on the program. Submissions received will be reviewed by the appointed Advisory Group and applicants will be contacted with further information once the evaluation process is complete by mid-September.
Conditions and requirements:
Submission Process: Please download and complete the template and return to firstname.lastname@example.org, with the email subject ‘Early Stage Investment Forum – <Project name> presentation submission’. The application will be reviewed by the Early Stage Investment Forum Advisory Group and applicants will be contacted by mid-September to indicate if they have been successful and will be invited to present on the day.
Deadline: submissions must be received by no later than 10 September 2018 (extended from the 31 August)
Contact: For further information, please contact email@example.com or +613 9828 1400.